Testing a new drug called BW-40202 in healthy people
This study tests a new medicine called BW-40202 for the first time in people. It is for healthy volunteers to see if the drug is safe and how it works in the body. You must be in good general health to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your weight is between 110 and 220 pounds (50-100 kg), and your BMI is between 18 and 32.
- You do not have any serious or long-term health condition, and your blood tests are normal.
- You have not been in the hospital in the last 2 months, and you have not had a fever or cold in the last 2 weeks.
- You do not have a history of alcohol or drug abuse in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, BW-50218, in healthy volunteers to see how safe it is and how the body processes it. If you are generally healthy and meet the specific requirements below, you may be able to help with early research on this potential treatment.
This is an early-stage (Phase 1) safety test of a new investigational drug called BW-20805-2-1001 in people without serious health conditions. Researchers want to understand how the drug is tolerated and processed by the body when given as an injection.
This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.
This study tests a new drug called DW5524 in healthy adults to see if it is safe and how the body processes it. It is a first step in finding out if the drug could be used for future treatments.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Healthy Volunteers Only trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.